Estimating the Prevalence of Fetal Alcohol Spectrum Disorder in Australia
Drug and Alcohol Review · 2025-07 · 44 (5) · 1522-1525
DOI: 10.1111/dar.14082 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug and Alcohol Review, online erschienen am 02.06.2025. Verfasst von Tracey W Tsang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Specialty of Child and Adolescent Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia. Hauptthemen laut MEDLINE: Fetal Alcohol Spectrum Disorders, Prenatal Exposure Delayed Effects. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Department of Health and Ageing, Australian Government.
Abstract (Originalsprache)
Introduction
Fetal alcohol spectrum disorder (FASD) is caused by prenatal alcohol exposure (PAE) and characterised by severe neurodevelopmental impairment. Australian studies have reported PAE prevalence of between 14% and 78% of births. Estimating national FASD prevalence in the general population using gold‐standard active case ascertainment is costly and time‐consuming, and alternative approaches are required.
Methods
Using a published equation for the risk of FASD following PAE (estimated from an international meta‐analysis) and a pooled estimate of PAE prevalence in Australia (from a meta‐analysis of 78 studies reporting 16 large general population‐based birth cohorts between 1975 and 2018), we estimated the population prevalence of FASD. Monte Carlo simulations were used to determine confidence intervals.
Results
Estimated FASD prevalence in the general population was 3.64% (95% confidence interval 2.91%, 4.41%). Discussion and Conclusions The estimated FASD prevalence in the general population of Australia was comparable to that in other high‐income countries (e.g., USA, Canada). Although it is likely that certain vulnerable populations have significantly higher FASD prevalence, this estimate provides a baseline estimate for the general population to inform service development and strategies for prevention of FASD and guide future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Specialty of Child and Adolescent Health, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
- Australian Paediatric Surveillance Unit, FASD Australian Registry, and Kids Research, Sydney Children's Hospitals Network, Sydney, Australia.
- Health Economics and Research Division, Australian Government Department of Health and Aged Care, Canberra, Australia.
ORCID-Profile: Tracey W Tsang, Daniel H Rosenblatt, Indra Parta, Elizabeth J Elliott
Förderung
- National Health and Medical Research Council
- Department of Health and Ageing, Australian Government
Zitieren
APA
Tsang, T. W., Rosenblatt, D. H., Parta, I., & Elliott, E. J. (2025). Estimating the Prevalence of Fetal Alcohol Spectrum Disorder in Australia. Drug and Alcohol Review, 44(5), 1522-1525. https://doi.org/10.1111/dar.14082
Vancouver
Tsang TW, Rosenblatt DH, Parta I, Elliott EJ. Estimating the Prevalence of Fetal Alcohol Spectrum Disorder in Australia. Drug and Alcohol Review. 2025;44(5):1522-1525. doi:10.1111/dar.14082
BibTeX
@article{Tsang2025,
author = {Tsang, Tracey W and Rosenblatt, Daniel H and Parta, Indra and Elliott, Elizabeth J},
title = {Estimating the Prevalence of Fetal Alcohol Spectrum Disorder in Australia},
journal = {Drug and Alcohol Review},
year = {2025},
volume = {44},
number = {5},
pages = {1522--1525},
doi = {10.1111/dar.14082}
}
EUVIMED